ArticleInternational journal of clinical pharmacy2015
Recommendations to support deprescribing medications late in life.
Article in International journal of clinical pharmacy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis.The oncologist · 2020Pooled it
- Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.Implementation science : IS · 2017Trial
- Deprescribing for People with Dementia: A Roadmap.Drugs & aging · 2025Review
- Managing Hypercholesterolemia in Adults Older Than 75 years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus From the National Lipid Association and the American Geriatrics Society.Journal of the American Geriatrics Society · 2025Article
- Better drug use in advanced disease: an international Delphi study.BMJ supportive & palliative care · 2023Article
- Deprescription in Palliative Care.Cureus · 2023Review
- Understanding older patients' willingness to have medications deprescribed in primary care: a protocol for a cross-sectional survey study in nine European countries.BMC geriatrics · 2022Article
- Palliative Care: A Primary Care Pharmacist Perspective.Pharmacy (Basel, Switzerland) · 2022Article
- Prescription trends at the end of life in a palliative care unit: observational study.BMC palliative care · 2022Observational
- Residential Medication Management Reviews and continuous polypharmacy among older Australian women.International journal of clinical pharmacy · 2021Article
- Barriers to effective prescribing in older adults: applying the theoretical domains framework in the ambulatory setting - a scoping review.BMC geriatrics · 2020Article
- TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilities.BMJ open · 2020Article
- What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.BMC geriatrics · 2020Article
- Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission.Journal of general internal medicine · 2019Article
- Deprescribing in palliative care.Clinical medicine (London, England) · 2019Article
- Prescription and deprescription of medications for older adults receiving palliative care during the last 3 months of life: a single-center retrospective cohort study.European geriatric medicine · 2019Article
- The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.BMC geriatrics · 2018Article
- How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study.BMC family practice · 2018Article
- Reply to: Comment on: "Incorporating Geriatric Assessment into a Nephrology Clinic: Preliminary Data from Two Models of Care".Journal of the American Geriatrics Society · 2017Article
- Review of structured guides for deprescribing.European journal of hospital pharmacy : science and practice · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
It is widely acknowledged that patients-particularly those late in life-are frequently exposed to the harms of medication. To minimize these harms, several frameworks have been developed by which prescribing can be optimized. In the context of diminishing life expectancy, these frameworks can be used to reduce medications that are no longer necessary, but appear to fall short of actual guidelines that incorporate a consideration of stopping medications. In this commentary, we present recommendations that could be incorporated into prescribing processes for all healthcare professionals and, ultimately, used to support the rationalization or deprescribing of medication in diminished life expectancy. We frame these recommendations in the same context as guidance for the initiation and discontinuation of implantable cardiac devices and argue that the two processes-with regards to decision-making-should be the same. We present our recommendations with preventive medication use in mind, and use statin therapy as an illustrative example.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.